AU2003275978A1 - Bile acid conjugates and particles formed therewith - Google Patents

Bile acid conjugates and particles formed therewith

Info

Publication number
AU2003275978A1
AU2003275978A1 AU2003275978A AU2003275978A AU2003275978A1 AU 2003275978 A1 AU2003275978 A1 AU 2003275978A1 AU 2003275978 A AU2003275978 A AU 2003275978A AU 2003275978 A AU2003275978 A AU 2003275978A AU 2003275978 A1 AU2003275978 A1 AU 2003275978A1
Authority
AU
Australia
Prior art keywords
bile acid
particles formed
formed therewith
acid conjugates
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275978A
Inventor
Gerhard Putz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003275978A1 publication Critical patent/AU2003275978A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
AU2003275978A 2002-10-25 2003-09-23 Bile acid conjugates and particles formed therewith Abandoned AU2003275978A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10249890.3 2002-10-25
DE10249890A DE10249890A1 (en) 2002-10-25 2002-10-25 Bile acid conjugates and particles formed with them
PCT/EP2003/010580 WO2004037275A1 (en) 2002-10-25 2003-09-23 Bile acid conjugates and particles formed therewith

Publications (1)

Publication Number Publication Date
AU2003275978A1 true AU2003275978A1 (en) 2004-05-13

Family

ID=32103041

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275978A Abandoned AU2003275978A1 (en) 2002-10-25 2003-09-23 Bile acid conjugates and particles formed therewith

Country Status (3)

Country Link
AU (1) AU2003275978A1 (en)
DE (1) DE10249890A1 (en)
WO (1) WO2004037275A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005045152A1 (en) * 2005-09-21 2007-03-22 Stremmel, Wolfgang, Prof. Dr. Use of therapeutically active lipids and methods for producing organ / tissue-specific therapeutically active lipids
CN105026030B (en) * 2012-12-21 2017-04-12 博莱科瑞士股份有限公司 Gas-filled microvesicles
WO2020260558A1 (en) 2019-06-27 2020-12-30 Phenex Pharmaceuticals Ag 3-modified iso-/isoallo-lithocholic acid derivatives or their homo-analogs for preventing and treating clostridioides difficile-associated diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
AU8285998A (en) * 1997-07-02 1999-01-25 Sdg, Inc. Targeted liposomal constructs for diagnostic and therapeutic uses
CA2397016C (en) * 2000-01-10 2011-03-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease

Also Published As

Publication number Publication date
DE10249890A1 (en) 2004-05-13
WO2004037275A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
AU2003293294A1 (en) Uv-stabilised particles
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
AU2003299778A1 (en) Antibodies against gpr64 and uses thereof
AU2003272187A1 (en) Novel nanoparticles and use thereof
AU2003241478A1 (en) Nanoparticulate sterol formulations and sterol combinations
AU2001292338A1 (en) Functional alloy particles
AU2003253048A1 (en) Tubulysin conjugates
AU2003264145A1 (en) Cyclodextrin particle
AU2003291527A1 (en) Antibody-containing particles and compositions
AU2003265576A1 (en) Corticosteroid conjugates and uses thereof
AU2003232821A1 (en) Novel phospholipases and uses thereof
AU2003205558A1 (en) Thioibotenic acid and derivatives thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003205381A1 (en) Hpma-polyamine conjugates and uses therefore
AU2003240281A1 (en) Cell targeting methods and compositions
AU2003214625A1 (en) Histone conjugates and uses thereof
AU2003242064A1 (en) Magnetite particles
AU2003230285A1 (en) Camptothecin-taxoid conjugates as antimitotic and antitumor agents
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2002366809A1 (en) Syn3 compositions and methods
AU2003275978A1 (en) Bile acid conjugates and particles formed therewith
AU2003228355A1 (en) Adipocytes and uses thereof
AU2003275240A1 (en) Methods and compositions for soluble cpg15
AU2003244927A1 (en) Forestalling long time-outs in processes
AUPS203902A0 (en) Framework and hold down connector

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase